Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Different Treatment Modalities of Oral Lichen Planus —A Narrative Review (CROSBI ID 323170)

Prilog u časopisu | stručni rad | međunarodna recenzija

Andabak-Rogulj, Ana ; Vindiš, Ema ; Horvat Aleksijević, Lorena ; Škrinjar, Ivana ; Vidović Juras, Danica ; Aščić, Anastazija ; Lončar Brzak, Božana Different Treatment Modalities of Oral Lichen Planus —A Narrative Review // Dentistry journal, 11 (2023), 1; 1-16. doi: 10.3390/dj11010026

Podaci o odgovornosti

Andabak-Rogulj, Ana ; Vindiš, Ema ; Horvat Aleksijević, Lorena ; Škrinjar, Ivana ; Vidović Juras, Danica ; Aščić, Anastazija ; Lončar Brzak, Božana

engleski

Different Treatment Modalities of Oral Lichen Planus —A Narrative Review

Oral lichen planus (OLP) is a chronic inflammatory disease of unknown etiology which affects the oral mucosa. OLP varies in its clinical features from a reticular form that is, in most cases, asymptomatic, to atrophic– erosive, and is accompanied by symptoms of burning sensation and pain followed by difficulty in eating. Given the fact that OLP is a disease of unknown etiology, the treatment is symptomatic and involves suppressing the signs and symptoms of the disease using various topical and systemic drugs. The first line of therapy for treating symptomatic OLP is topical corticosteroids, whereas systemic corticosteroids are used for treating persistent lesions that do not respond to local treatment. However, the lack of convincing evidence on the efficacy of previous therapies, including topical corticosteroids, and numerous side effects that have appeared over recent years has resulted in the emergence and development of new therapeutic options. Some of the therapies mentioned are tacrolimus, efalizumab, dapson, interferon, retinoic acid, photochemotherapy with psoralen and ultraviolet A rays (PUVA), aloe vera, antimalarials, antibiotics and others. These therapies only partially meet the properties of efficacy and safety of use, thus justifying the continuous search and testing of new treatment methods.

oral lichen planus ; chronic disease ; therapeutics ; adverse effects

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

11 (1)

2023.

1-16

objavljeno

2304-6767

10.3390/dj11010026

Povezanost rada

Dentalna medicina

Poveznice
Indeksiranost